Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Precision medicine for autoimmune disease.

Literature DB >> 27606458

Precision medicine for autoimmune disease.

Lucienne Chatenoud¹.

Abstract

Entities: Disease

Mesh：

Year: 2016 PMID： 27606458 DOI： 10.1038/nbt.3670

Source DB: PubMed Journal: Nat Biotechnol ISSN： 1087-0156 Impact factor: 54.908

× No keyword cloud information.

11 in total

Review 1. The effect of infections on susceptibility to autoimmune and allergic diseases.

Authors: Jean-Francois Bach
Journal: N Engl J Med Date: 2002-09-19 Impact factor: 91.245

Review 2. Biotherapies targeting T and B cells: from immune suppression to immune tolerance.

Authors: Lucienne Chatenoud
Journal: Curr Opin Pharmacol Date: 2015-06-19 Impact factor: 5.547

3. Main immunogenic region structure promotes binding of conformation-dependent myasthenia gravis autoantibodies, nicotinic acetylcholine receptor conformation maturation, and agonist sensitivity.

Authors: Jie Luo; Palmer Taylor; Mario Losen; Marc H de Baets; G Diane Shelton; Jon Lindstrom
Journal: J Neurosci Date: 2009-11-04 Impact factor: 6.167

Review 4. Molecular mechanisms of congenital heart block.

Authors: Aurélie Ambrosi; Sven-Erik Sonesson; Marie Wahren-Herlenius
Journal: Exp Cell Res Date: 2014-01-13 Impact factor: 3.905

5. Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease.

Authors: Christoph T Ellebrecht; Vijay G Bhoj; Arben Nace; Eun Jung Choi; Xuming Mao; Michael Jeffrey Cho; Giovanni Di Zenzo; Antonio Lanzavecchia; John T Seykora; George Cotsarelis; Michael C Milone; Aimee S Payne
Journal: Science Date: 2016-06-30 Impact factor: 47.728

Review 6. Preventing congenital neonatal heart block in offspring of mothers with anti-SSA/Ro and SSB/La antibodies: a review of published literature and registered clinical trials.

Authors: Norbert Gleicher; Uri Elkayam
Journal: Autoimmun Rev Date: 2013-05-15 Impact factor: 9.754

7. Outcome in 212 anti-Ro/SSA-positive pregnancies and population-based incidence of congenital heart block.

Authors: Amanda Skog; Linda Lagnefeldt; Peter Conner; Marie Wahren-Herlenius; Sven-Erik Sonesson
Journal: Acta Obstet Gynecol Scand Date: 2015-10-26 Impact factor: 3.636

8. B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD.Ig mu null mice.

Authors: D V Serreze; H D Chapman; D S Varnum; M S Hanson; P C Reifsnyder; S D Richard; S A Fleming; E H Leiter; L D Shultz
Journal: J Exp Med Date: 1996-11-01 Impact factor: 14.307

Precision medicine for autoimmune disease.

Review 1. The effect of infections on susceptibility to autoimmune and allergic diseases.

Review 2. Biotherapies targeting T and B cells: from immune suppression to immune tolerance.

3. Main immunogenic region structure promotes binding of conformation-dependent myasthenia gravis autoantibodies, nicotinic acetylcholine receptor conformation maturation, and agonist sensitivity.

Review 4. Molecular mechanisms of congenital heart block.

5. Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease.

Review 6. Preventing congenital neonatal heart block in offspring of mothers with anti-SSA/Ro and SSB/La antibodies: a review of published literature and registered clinical trials.

7. Outcome in 212 anti-Ro/SSA-positive pregnancies and population-based incidence of congenital heart block.

8. B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD.Ig mu null mice.

9. Persistence of anti-desmoglein 3 IgG(+) B-cell clones in pemphigus patients over years.

Review 10. Pathogenesis of myasthenia gravis: update on disease types, models, and mechanisms.

Review 1. Pemphigus: Current and Future Therapeutic Strategies.

Review 2. Type I Interferons in Systemic Lupus Erythematosus: A Journey from Bench to Bedside.

Review 3. Clinical development of CAR T cell therapy in China: 2020 update.

Review 4. Immunotherapy Deriving from CAR-T Cell Treatment in Autoimmune Diseases.